Showing 133–140 of 140 results

Show sidebar
Show 9 12 18 24
Compare

Yuflyma (adalimumab-aaty)

£1,359.49 – £3,533.18
Yuflyma (adalimumab-aaty) is a prescription medicine for the treatment of multiple conditions, including plaque psoriasis, psoriatic and rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, axial spondyloarthritis, Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and non-infectious uveitis
Add to wishlist
Select options
Quick view
Compare

Yupelri (revefenacin)

Yupelri (revefenacin) is a nebulized maintenance medicine used to treat chronic obstructive pulmonary disease (COPD.
Add to wishlist
Price available on request
Quick view
Compare

Zavedos (idarubicin) (idarubicin)

£152.19 – £244.82
Zavedos (Idarubicin Hydrochloride) is a prescription medicine for the treatment of acute myelogenous leukaemia (AML) in adults. Zavedos may be used together with chemotherapy regimens involving other cytotoxic agents 1. Zavedos (Idarubicin Hydrochloride) is approved by the FDA in the USA, the EMA in the EU, and the MHRA in the UK.
Add to wishlist
Select options
Quick view
Compare

Zegalogue (dasiglucagon)

£282.33 – £650.00
Zegalogue (dasiglucagon) is a rescue treatment used for severe low blood sugar (hypoglycemia) in people with diabetes.
Add to wishlist
Select options
Quick view
Compare

Zejula (niraparib)

£3,086.42 – £4,093.50

Zejula (niraparib) is a medication used for the treatment of recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.

For this product the estimated delivery time is usually between 10 and 20 working days.

Add to wishlist
Select options
Quick view
Zepbound for weight Loss
Compare

Zepbound weight Loss

£125.00 – £169.00
Zepbound is a new weight loss medication approved by the FDA. It helps adults with excess weight or obesity lose weight.
Add to wishlist
Select options
Quick view
Compare

Zokinvy (lonafarnib)

£17,500.00 – £28,500.00
Zokinvy (lonafarnib) is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome (HGPS) or certain types of Progeroid Laminopathies in patients one year of age and older. It is the first FDA-approved medication for these diseases.
Add to wishlist
Select options
Quick view
Compare

Zoryve (roflumilast)

£450.00
Zoryve (roflumilast) cream 0.3% is a topical PDE4 inhibitor indicated for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. Zoryve was approved by the FDA in July 2022.
Add to wishlist
Add to cart
Quick view